The pain of being sick: Implications of immune-to-brain communication for understanding pain

Annual Review of Psychology

Volumn 51, Issue , 2000, Pages 29-57

  Watkins, L R ^a   Maier, S F ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Allodynia; Hyperalgesia; Interleukin 1; Nerve growth factor; Review; Tumor necrosis factor

Indexed keywords

CYTOKINE;

ANALGESIA; CENTRAL NERVOUS SYSTEM; HUMAN; HYPERALGESIA; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGY; INHIBITION (PSYCHOLOGY); NERVE CELL NETWORK; PAIN; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW;

ANALGESIA; CENTRAL NERVOUS SYSTEM; CYTOKINES; HUMANS; HYPERALGESIA; IMMUNE SYSTEM; IMMUNITY; INHIBITION (PSYCHOLOGY); NERVE NET; PAIN;

EID: 0033656015     PISSN: 00664308     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.psych.51.1.29     Document Type: Article

References (161)

1. Baber NS, Dourish CT, Hill DR. 1989. The role of CCK caerulein, and CCK antagonists in nociception. Pain 39:307-28
2. Baldwin RL, Stolowitz ML, Hood L, Wisnieski BJ. 1996. Structural changes of tumor necrosis factor alpha associated with membrane insertion and channel formation. Proc. Natl. Acad. Sci. USA 93:1021-26
3. Becher B, Fedorowicz V, Antel JP. 1996. Regulation of CD14 expression on human adult central nervous system-derived microglia. J. Neurosci. Res. 45:375-81
4. Benedetti F, Amanzio M. 1997. The neurobiology of placebo analgesia: from endogenous opioids to cholecystokinin. Prog. Neurobiol. 52:109-25
5. Bian D, Ossipov MH, Zhong C, Malan TP Jr, Porreca F. 1998. Tactile allodynia, but not thermal hyperalgesia, of the hindlimbs is blocked by spinal transection in rats with nerve injury. Neurosci. Lett. 241: 79-82
6. Bolin LM, Verity AN, Silver JE, Shooter EM, Abrams JS. 1995. Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J. Neurochem. 65:850-58
7. Breitbart W, McDonald M, Rosenfeld B, Passik S, Hewitt D, et al. 1996. Pain in ambulatory AIDS patients: pain characteristics and medical correlates. Pain 68:315-21
8. Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L. 1998. Acute inflammatory response in spinal cord following impact injury. Exp. Neurol. 151:77-88
9. Cesselin F. 1995. Opioid and anti-opioid peptides. Fundam. Clin. Pharmacol. 9:409-33
10. Christensen MD, Hulsebosch CE. 1997. Chronic central pain after spinal cord injury. J. Neurotrauma 14:517-37
11. Clatworthy AL. 1999. Evolutionary perspectives of cytokines in pain. See Watkins & Maier 1999c, pp. 21-38
12. Clatworthy AL, Grose EF. 1997. Immune cells release factors that modlate the excitability of nociceptive sensory neurons in Aplysia. Soc. Neurosci. Abstr. 23:166
13. Clatworthy AL, Hughes TK, Budelmann BU, Castro GA, Walters ET. 1994. Cytokines may act as signals for the injury-induced hyperexcitability in nociceptive sensory neurons in Aplysia. Soc. Neurosci. Abstr. 23:166
14. Clatworthy AL, Illich PA, Castro GA, Walters ET. 1995. Role of periaxonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain. Neurosci. Lett. 184:5-8
15. Clatworthy AL, Walters ET. 1994. Comparative analysis of hyperexcitability and synaptic facilitation induced by nerve injury in cerebral and pleural mechanosensory neurons in Aplysia. J. Exp. Biol. 190:217-38
16. Codazzi F, Racchetti G, Grohovaz F, Meldolesi J. 1996. Transduction signals induced in the rat brain cortex astrocytes by the HIV gp120 glycoprotein. FEBS Lett. 384:135-37
17. Coyle DE. 1998. Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior. Glia 23:75-83
18. Cunha Q, Poole S, Lorenzetti BB, Ferreira SH. 1992. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br. J. Pharmacol. 107:660-64
19. DeLeo JA, Colburn RW. 1999. Proinflammatory cytokines and glial cells: their role in neuropathic pain. See Watkins & Maier 1999c, pp. 159-82
20. DeLeo JA, Colbum RW, Nichols M, Malhotta A. 1996. Interleukin-6-mediated hyperalgesia/ allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J. Interferon Cytokine Res. 16:695-700
21. Diederich N, Acermann R, Jurgens R, Ortseifen M, Thun F, et al. 1988. Early involvement of the nervous system by human immune deficiency virus (HIV). A study of 79 patients. Eur. Neurol. 28:93-103
22. Doyere V, Burette F, Redinidel-Negro CR, Laroche S. 1993. Long-term potentiation of hippocampal afferents and efferents to prefrontal cortex: implications for associative learning. Neuropsychologia 31:1031-53
23. Ek M, Kurosawa M, Lundeberg T, Ericsson A. 1998. Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J. Neurosci. 18:9471-79
24. Eliav E, Ruda MA, Bennett GJ. 1996. An experimental neuritis of the rat sciatic nerve produces ipsilateral hindpaw allodynia and hyperalgesia. Proc. Soc. Neurosci. 22:865
25. Faris PL, Komisaruk B, Watkins LR, Mayer DJ. 1983. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science 219:310-12
26. Ferreira SH. 1972. Aspirin-like drugs and analgesia. Nat. New Biol. 240:200-3
27. Ferreira SH, Lorenzetti BB, Bristow AF, Poole S. 1988. Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334:698-700
28. Follenfant RL, Nakamura-Craing M, Henderson B, Higgs GA. 1989. Inhibition by neuropeptides of interleukin-1-beta-induced, prostaglandin-independent hyperalgesia. Br. J. Pharmacol. 98:41-43
29. Fu K, Light AR, Maixner W. 1998. Long-lasting inflammation and hyperalgesia evoked by subcutaneous formalin injection: associated with spinal microglial activation. Proc. Soc. Neurosci. 24:152.2
30. Fukuota H, Kawatani M, Hisamitsu T, Takeshige C. 1994. Cutaneous hyperalgesia induced by peripheral injection of interleukin-1 beta in the rat. Brain Res. 657:133-40
31. Garrison CJ, Dougherty PM, Kajander KC, Carlton SM. 1991. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res. 565:1-7
32. Gaykema RPA, Goehler LE, Tilders FJH, Bol JGJM, McGorry M, et al. 1998. Bacterial endotoxin induces Fos immunoreactivity in primary afferent neurons of the vagus nerve. NeuroImmunoModulation 5:234-40
33. Gilmer WS. 1995. Neurologic conditions affecting the lower extremities in HIV infection. J. Am. Podiatr. Med. Assoc. 85:352-61
34. Goehler LE, Gaykema RPA, Hammack SE, Maier SF, Watkins LR. 1998. Interleukin-1 induces c-Fos immunoreactivity in primary afferent neurons of the vagus nerve. Brain Res. 804:306-10
35. Goehler LE, Gaykema RPA, Nguyen KT, Lee JE, Tilders FJH, et al. 1999. Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems? J. Neurosci. 19:2799-2806
36. Goehler LE, Relton JK, Dripps D, Kiechle R, Tartaglia N, et al. 1997. Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist (IL-1ra) in the rat: a possible mechanism for immune-to-brain communication. Brain Res. Bull. 43:357-64
37. Gunstream JD, Castro GA, Walters ET. 1995. Retrograde transport of plasticity signals in Aplysia sensory neurons following axonal injury. J. Neurosci. 15:439-48
38. Hadley SD, Goshgarian HG. 1997. Altered immunoreactivity for glial fibrillary acidic protein in astrocytes within 1 h after cervical spinal cord injury. Exp. Neurol. 146:380-87
39. Hammack S, Milligan E, Nguyen K, Hansen M, Martin D, et al. 1999. Sciatic nerve neuritis-induced allodynia and hyperalgesia is blocked by intrathecal application of IL-1 receptor antagonist. Proc. Soc. Neurosci. 25: In press
40. Hart BL. 1988. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 12:123-37
41. Hattori A, Tanaka E, Murase K, Ishida N, Chatani Y, et al. 1993. Tumor necrosis factor stimulates the synthesis and secretion of biologically active nerve growth factor in non-neuronal cells. J. Biol. Chem. 268:2577-82
42. Herzberg U, Eliav E, Dorsey JM, Gracely RH, Kopin IJ. 1997. NGF involvement in pain induced by chronic constriction injury of the rat sciatic nerve. NeuroReport 8:1613-18
43. Herzberg U, Frydel BR, Sagen J. 1998. Epineural exposure to HIV viral envelope protein gp120 induces painful peripheral mononeuropathy and spinal gliosis. Proc. Soc. Neurosci. 24:547.4
44. Hewitt D, McDonald M, Pertenoy R, Rosenfeld B, Passik S, et al. 1997. Pain syndromes and etiologies in ambulatory AIDS patients. Pain 70:117-23
45. Hughes TK, Smith EM, Leung MK, Stefano GB. 1992. Immunoreactive cytokines in Mytilus edulis nervous and immune interactions. Acta Biol. Hung. 43:269-73
46. Illich PA, Martin D, Castro GA, Clatworthy AL. 1997. TNF binding protein attenuates thermal hyperalgesia but not guarding behavior following loose ligation of rat sciatic nerve. Soc. Neurosci. Abstr. 23:166
47. Johnson D, Krenger W. 1992. Interactions of mast cells with the nervous system - recent advances. Neurochem. Res. 17:939-51
48. Kagan BL, Baldwin R, Munoz D, Wisnieski BJ. 1992. Formation of ion-permeable channels by tumor necrosis factor-alpha. Science 255:1427-30
49. Kang JD, Stefanovic-Racic M, McIntyre LA, Georgescu HI, Evans CH. 1997. Toward a biochemical understanding of human intervertebral disc degeneration and herniation. Contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases. Spine 22:1065-73
50. Kaplan H, Fields HL. 1991. Hyperalgesia during acute opioid abstinence: evidence for a nociceptive facilitating function of the rostral ventromedial medulla. J. Neurosci. 11:1433-39
51. Kawatani M, Birder L. 1992. Interleukin-1 facilitates Ca2+ release in acutely dissociated dorsal root ganglion (DRG) cells of rat. Proc. Soc. Neurosci. 18:691
52. Kellstein DE, Mayer DJ. 1991. Spinal co-administration of cholecystokinin antagonists with morphine prevents the development of opioid tolerance. Pain 47:221-29
53. Kelly DC, Asghar AUR, McQueen DS, Perkins MN. 1996. Effects of bradykinin and desArg9-bradykinin on afferent neural discharge in interleukin-1beta-treated knee joints. Br. J. Pharmacol. 117:90P
54. Kelly DD, ed. 1986. Annals of the New York Academy of Sciences: Stress Induced Analgesia, Vol. 467. New York: NY Acad. Sci.
55. Kluger MJ. 1978. The evolution and adaptive value of fever. Am. Sci. 66:38-43
56. Kluger MJ. 1991. Fever: role of pyrogens and cryogens. Physiol. Rev. 71:93-127
57. Koka P, He K, Ja Z, Kitchen S, Peacock W, et al. 1995. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal and adult human brain. J. Exp. Med. 182:941-51
58. Kuby J. 1992. Immunology. New York: Freeman
59. Laye S, Bluthe R-M, Kent S, Combe C, Medina C, et al. 1995. Subdiaphragmatic vagotomy blocks the induction of interleukin-1b mRNA in the brain of mice in response to peripherally administered peripheral lipopolysaccharide. Am. J. Physiol. 268:R1327-31
60. Lindholm D, Heumann R, Hengerer B, Thoenen H. 1988. Interleukin-1 increases stability and transcription of mRNA encoding nerve growth factor in cultured rat fibroblasts. J. Biol. Chem. 263:16348-51
61. Lindholm D, Heumann R, Meyer M, Thoenen H. 1987. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 330:658-59
62. Liu XG, Sandkuhler J. 1998. Activation of spinal N-methyl-D-aspartate or neurokinin receptors induces long-term potentiation of spinal C-fibre-evoked potentials. Neuroscience 86:1209-16
63. Ma M, Geiger JD, Nath A. 1994. Characterization of a novel binding site for the human immunodeficiency virus type 1 envelope protein gp120 on human fetal astrocytes. J. Virol. 68:6824-28
64. Maier SF, Goehler LE, Fleshner M, Watkins LR. 1998. The role of the vagus nerve in cytokine-to-brain communication. Ann. NY Acad. Sci. 840:289-300
65. Maier SF, Watkins LR. 1998. Cytokines for psychologists: implications of bi-directional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol. Rev. 105:83-107
66. Maier SF, Wiertelak EP, Martin D, Watkins LR. 1993. Interleukin-1 mediates behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res. 623:321-24
67. Maier SF, Wiertelak EP, Watkins LR. 1992. Endogenous pain facilitatory systems: anti-analgesia and hyperalgesia. Am. Pain Soc. J. 1:191-98
68. Martin D. 1999. Interleukin-1 and tumor necrosis factor: rheumatoid arthritis and pain. See Watkins & Maier 1999c, pp. 205-20
69. Mason P. 1993. Lipopolysaccharide induces fever and decreases tail flick latency in awake rats. Neurosci. Lett. 154:134-36
70. Maves TJ, Pechman PS, Gebhart GF, Meller ST. 1993. Possible chemical contribution from chromic gut sutures produces disorders of pain sensation like those seen in man. Pain 54:57-69
71. McMahon SB, Bennett DLH, Priestley JV, Shelton DL. 1995. The biological effects of endogenous NGF in adult sensory neurones revealed by a trkA IgG fusion molecule. Nat. Med. 1:774-80
72. Meller ST, Dyskstra C, Grzybycki D, Murphy S, Gebhart GF. 1994. The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology 33:1471-78
73. Milligan E, Nguyen K, Hansen M, Martin D, Maier SF, et al. 1999. HIV-1 gp120-enhanced pain responsivity is mediated by activated spinal cord glia. Proc. Soc. Neurosci. 25: In press
74. Milligan ED, Nguyen KT, Hansen M, Maier SF, Watkins LR. 1998. Allodynia and increased dorsal spinal cord interleukin-1beta induced by intrathecal (IT) gp120, an HIV-1 envelope glycoprotein. Proc. Soc. Neurosci. 24:155.1
75. Misery L. 1998. Langerhans cells in the neuroimmuno-cutaneous system. J. Neuroimmunol. 89:83-87
76. Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, et al. 1997. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 337:141-47
77. Myers RR, Wagner R, Sorkin LS. 1999. Hyperalgesic actions of cytokines on peripheral nerves. See Watkins & Maier 1999c, pp. 133-58
78. Nguyen KT, Deak T, Owens SM, Kohno T, Fleshner M, et al. 1998. Exposure to acute stress induces brain interleukin-1beta protein in the rat. J. Neurosci. 18:2239-46
79. Nichols ML, Bian D, Ossipov MH, Lai J, Porreca F. 1995. Regulation of morphine antiallodynic efficacy by cholecystokinin in a model of neuropathic pain in rats. J. Pharmacol. Exp. Ther. 275:1339-45
80. Nuki G, Rozman B, Pavelka K, Emery P, Lockabaugh J, et al. 1997. Interleukin-1 receptor antagonist continues to demonstrate clinical improvement in rheumatoid arthritis. Arthritis Rheum. 40:S224
81. Oka T, Aou S, Hori T. 1993. Intracerebroventricular injection of interleukin-1β induces hyperalgesia in rats. Brain Res. 624:61-68
82. Oka T, Aou S, Hori T. 1994a. Intracerebroventricular injection of interleukin-1β enhances nociceptive neuronal responses of the trigeminal nucleus caudalis in rats. Brain Res. 656:236-44
83. Oka T, Aou S, Hori T. 1994b. Intracerebroventricular injection of prostaglandin E2 induces thermal hyperalgesia in rats: the possible involvement of EP3 receptors. Brain Res. 663:287-92
84. Oka T, Hori T. 1999. Brain cytokines and pain. See Watkins & Maier 1999c, pp. 183-204
85. Oka T, Hori T, Hosoi M, Oka K, Abe M, et al. 1997. Biphasic modulation in the trigerminal nociceptive neuronal responses by the intracerebroventricular prostaglandin E2 may be mediated through different EP receptor subtypes in rats. Brain Res. 771:278-84
86. Oka T, Oka K, Hosoi M, Aou S, Hori T. 1995a. The opposing effects of interleukin-1β microinjected into the preoptic hypothalamus and the ventromedial hypothalamus on nociceptive behavior in rats. Brain Res. 700:271-78
87. Oka T, Oka K, Hosoi M, Hori T. 1995b. Intracerebroventricular injection of interleukin-6 induces thermal hyperalgesia in rats. Brain Res. 692:123-28
88. Oka T, Oka K, Hosoi M, Hori T. 1996a. Inhibition of peripheral interleukin-1β-induced hyperalgesia by the intracerebroventricular administration of diclofenac and α-melanocyte-stimulating hormone. Brain Res. 736:237-42
89. Oka T, Wakugawa Y, Hosoi M, Oka K, Hori T. 1996b. Intracerebroventricular injection of tumor necrosis factor-α induces thermal hyperalgesia in rats. NeuroImmunoModulation 3:135-40
90. Opp M, Rady P, Hughes T, Cadet P, Tyring S, et al. 1996. Human immunodeficiency virus envelope glycoprotein 120 alters sleep and induces cytokine mRNA expression in rats. Am. J. Physiol. 270:R963-70
91. Payza K, Akar CA, Yang HYT. 1993. Neuropeptide FF receptors: structure-activity relationship and effect of morphine. J. Pharmacol. Exp. Ther. 267:88-94
92. Pertovaara A. 1998. A neuronal correlate of secondary hyperalgesia in the rat spinal dorsal horn is submodality selective and facilitated by supraspinal influence. Exp. Neurol. 149:193-202
93. Peterson PK, Gekker G, Hu S, Sheng WS, Anderson WR, et al. 1995. CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect. Immun. 63:1598-602
94. Poole S, Bristow AF, Lorenzetti BB, Das REG, Smith TW, et al. 1992. Peripheral analgesic activities of peptides related to alpha-MSH and interleukin-1 beta 193-195. Br. J. Pharmacol. 106:489-92
95. Poole S, Cunha FDQ, Ferreira SH. 1999. Hyperalgesia from subcutaneous cytokines. See Watkins & Maier 1999c, pp. 59-88
96. Poole S, Woolf CJ. 1999. Cytokine-nerve growth factor interactions in inflammatory hyperalgesia. See Watkins & Maier 1999c, pp. 89-132
97. Popovich PG, Wei P, Stokes BT. 1997. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377:443-64
98. Rand N, Reichert F, Florman Y, Rotshenker S. 1997. Murine nucleus pulposus-derived cells secrete interleukins-1-beta, -6, and -10 and granulocyte-macrophage colony-stimulating factor in cell culture. Spine 22:2598-602
99. Redford FJ, Hall SM, Smith KJ. 1995. Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor. Brain 118:869-78
100. Reeve AJ, Fox A, Walker MJK, Urban L. 1998. Electrophysiological study on the spinal effects of interleukin-1βon the responses of dorsal horn neurones. Proc. Soc. Neurosci. 24:155.3
101. Ren K, Dubner R. 1996. Enhanced descending modulation of nociception in rats with persistent hindpaw inflammation. J. Neurophysiol. 76:3025-37
102. Richardson DE. 1995. Deep brain stimulation for the relief of chronic pain. Neurosurg. Clin. N. Am. 6:135-44
103. Richardson PM, Murphy PG, Ramer MS, Borthwick L, Bisby MA. 1998. Endogenous interleukin 6 contributes to peripheral neuropathic pain. Proc. Soc. Neurosci. 24:548.7
104. Ritter S, Ritter RC, Barnes CD. 1992. Neuroanatomy and Physiology of Abdominal Vagal Afferents. Ann Arbor, MI: CRC
105. Rothwell NJ, Luheshi G. 1994. Pharmacology of interleukin-1 actions in the brain. Adv. Pharmacol. 25:1-20
106. Rotshenker S, Aamar S, Barak V. 1992. Interleukin-1 activity in lesioned peripheral nerve. J. Neuroimmunol. 39:75-80
107. Rowbotham MC, Fields HL. 1996. The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia. Brain 119:347-54
108. Safieh-Garabedian B, Poole S, Allchorne A, Winter J, Woolf CJ. 1995. Contribution of interleukin-1b to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br. J. Pharmacol. 115:1265-75
109. Said G, Hontebeyrie-Joskowicz M. 1992. Nerve lesions induced by macrophage activation. Res. Immunol. 143:589-99
110. Sandkuhler J. 1996. The organization and function of endogenous antinociceptive systems. Prog. Neurobiol. 50:49-81
111. Sandkuhler J, Liu X. 1998. Induction of long-term potentiation at spinal synapses by noxious stimulation or nerve injury. Eur. J. Neurosci. 10:2476-80
112. Sharpless NE, O'Brien WA, Verdin E, Kukta CV, Chen IS, et al. 1992. Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism. J. Virol. 66:2588-93
113. Slart R, Yu AL, Yaksh TL, Sorkin LS. 1997. An animal model of pain produced by systemic administration of an immunotherapeutic antiganglioside antibody. Pain 69:119-25
114. Smith LC, Hildemann WH. 1986. Allogeneic cell interactions during graft rejection in Callyspongia diffusa (Porifera, Demospongia); a study with monoclonal antibodies. Proc. R. Soc. London Ser. B 226:465-77
115. Sommer C, Galbraith JA, Heckman HM, Myers RR. 1993. Pathology of experimental compression neuropathy producing hyperesthesia. J. Neuropath. Exp. Neurol. 52:223-33
116. Sommer C, Lindenlaub L, Petrausch S, George A. 1998a. Neutralizing antibodies to interleukin-1-receptor attenuate hyperalgesia in experimental painful mononeuropathy. Proc. Soc. Neurosci. 24:495.4
117. Sommer C, Marziniak M, Myers RR. 1998b. The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve. Pain 74:83-91
118. Sommer C, Schafers M. 1998. Painful mononeuropathy in C57BL/Wld mice with delayed Wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity. Brain Res. 784:154-62
119. Sommer C, Schmidt C, George A. 1998c. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Exp. Neurol. 151:138-42
120. Sommer C, Schmidt C, George A, Toyka KV. 1997. A metalloprotease-inhibitor reduces pain associated behavior in mice with experimental neuropathy. Neurosci. Lett. 237:45-48
121. Sorkin LS, Xiao WH, Wagner R, Myers RR. 1997. Tumor necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibers. Neuroscience 81:255-62
122. Swanson B, Zeller JM, Paice JA. 1998. HIV-associated distal symmetrical polyneuropathy: clinical features and nursing management. J. Assoc. Nurses AIDS Care 9:77-80
123. Sweitzer SM, Colburn RW, Rutkowski M, DeLeo JA. 1999. Acute peripheral inflammation induces moderate glial activation and spinal IL-1β expression that correlates with pain behavior in the rat. Brain Res. In press
124. Tang NM, Dong HW, Wang XM, Tsui ZC, Han JS. 1997. Cholecystokinin antisense RNA increases the analgesic effect induced by electroacupuncture or low dose morphine: conversion of low responder rats into high responders. Pain 71:71-80
125. Tyor WR, Glass JD, Griffin J, Becker PS, McArthur JC, et al. 1992. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31:349-60
126. Ushijima H, Nishio O, Klocking R, Perovic S, Muller WEG. 1995. Exposure to gp120 of HIV-1 induces an increased release of arachidonic acid in rat primary neuronal cell culture followed by NMDA receptor-mediated neurotoxicity. Eur. J. Neurosci. 7:1353-59
127. Vasko MR. 1995. Prostaglandin-induced neuropeptide release from spinal cord. Prog. Brain Res. 104:367-80
128. Vesce S, Bezzi P, Rossi D, Meldolesi J, Volterra A. 1997. HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid. FEBS Lett. 411:107-9
129. Wagner R, Janjigian M, Myers RR. 1998. Antiinflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression. Pain 74:35-42
130. Wagner R, Myers RR. 1996a. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. NeuroReport 7:2897-901
131. Wagner R, Myers RR. 1996b. Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience 73:625-29
132. Walters ET, Alizadeh H, Castro GA. 1991. Similar neuronal alterations induced by axonal injury and learning in Aplysia. Science 253:797-99
133. Wang CX, Olschowka JA, Wrathall JR. 1997. Increase of interleukin-1b mRNA and protein in the spinal cord following experimental traumatic injury of the rat. Brain Res. 759:190-97
134. Watkins LR, Deak T, Silbert L, Martinez J, Goehler L, et al. 1995a. Evidence for involvement of spinal cord glia in diverse models of hyperalgesia. Proc. Soc. Neurosci. 21:897
135. Watkins LR, Goehler LE, Relton J, Brewer MT, Maier SF. 1995b. Mechanisms of tumor necrosis factor-α (TNF-α) hyperalgesia. Brain Res. 692:244-50
136. Watkins LR, Kinscheck IB, Mayer DJ. 1984. Potentiation of opiate analgesia and apparent reversal of morphine tolerance by cholecystokinin antagonists. Science 224:395-96
137. Watkins LR, Maier SF. 1997. The case of the missing brain: arguments for a role of brain-to-spinal cord pathways in pain facilitation. Behav. Brain Sci. 20:469-70
138. Watkins LR, Maier SF. 1999a. Illness-induced hyperalgesia: mediators, mechanisms and implications. See Watkins & Maier 1999c, pp. 39-58
139. Watkins LR, Maier SF. 1999b. Implications of immune-to-brain communication for sickness and pain. Proc. Natl. Acad. Sci. USA. In press
140. Watkins LR, Maier SF, eds. 1999c. Cytokines and Pain. Basel: Birkhauser
141. Watkins LR, Maier SF, Goehler LE. 1995c. Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci. 57:1011-26
142. Watkins LR, Maier SF, Goehler LE. 1995d. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63:289-302
143. Watkins LR, Martin D, Ulrich P, Tracey KJ, Maier SF. 1997a. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 71:225-35
144. Watkins LR, Mayer DJ. 1986. Multiple endogenous opiate and non-opiate analgesia systems: evidence for their existence and clinical implications. Ann. NY Acad. Sci. 1st Int. Conf. Stress-Induced Analgesia, ed. DD Kelly, 467:273-99. New York: NY Acad. Sci. Press
145. Watkins LR, McGorry M, Schwartz B, Sisk D, Wiertelak EP, et al. 1997b. Reversal of spinal cord non-opiate analgesia by conditioned antianalgesia in the rat. Pain 71:237-47
146. Watkins LR, Wiertelak EP, Goehler LE, Smith KP, Martin D, et al. 1994. Characterization of cytokine-induced hyperalgesia. Brain Res. 654:15-26
147. Watkins LR, Wiertelak EP, McGorry M, Martinez J, Schwartz B, et al. 1998. Neurocircuitry of conditioned inhibition of analgesia: effects of amygdala, dorsal raphe, ventral medullary, and spinal cord lesions on antianalgesia. Behav. Neurosci. 112:360-78
148. Wiertelak EP, Maier SF, Watkins LR. 1992a. Cholecystokinin antianalgesia: safety cues abolish morphine analgesia. Science 256:830-33
149. Wiertelak EP, Roemer B, Maier SF, Watkins LR. 1997. Comparison of the effects of nucleus tractus solitarius and ventral medulla lesions on illness-induced and subcutaneous formalin-induced hyperalgesias. Brain Res. 748:143-50
150. Wiertelak EP, Watkins LR, Maier SF. 1992b. Conditioned inhibition of analgesia. Anim. Learn. Behav. 20:339-49
151. Wiertelak EP, Yang H-YT, Mooney-Heiberger K, Maier SF, Watkins LR. 1994. The nature of conditioned anti-analgesia: spinal cord opiate and antiopiate neurochemistry. Brain Res. 634:214-26
152. Willis WD, ed. 1992. Hyperalgesia and Allodynia. New York: Raven
153. Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S. 1997. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor α. Br. J. Pharmacol. 121:417-24
154. Woolf CJ, Safieh-Garabedian B, Ma Q-P, Crilly P, Winter J. 1994. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 62:327-31
155. Xiao WH, Wagner R, Myers RR, Sorkin LS. 1996. TNFa in the peripheral receptive field or on the sciatic nerve trunk evokes activity in primary afferent fibres. Proc. Soc. Neurosci. 22:1811
156. Xu XJ, Hao JX, Seiger A, Hughes J, Hokfelt T, et al. 1994. Chronic pain-related behaviors in spinally injured rats: evidence for functional alterations of the endogenous cholecystokinin and opioid systems. Pain 56:271-77
157. Xu XJ, Hao JX, Seiger A, Wiesenfeld-Hallin Z. 1993. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats. J. Pharmacol. Exp. Ther. 267:140-44
158. Yabuuchi K, Nishiyori A, Minami M, Satoh M. 1996. Biphasic effects of intracerebroventricular interleukin-1β on mechanicalnociception in the rat. Eur. J. Pharmacol. 300: 59-65
159. Yaksh TL. 1997. Pharmacology and mechanisms of opioid analgesic activity. Acta Anaesthesiol. Scand. 41:94-111
160. Yeung M, Pulliam L, Lau A. 1995. The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha. AIDS 9:137-43
161. Zimmermann M, Herdegen T. 1996. Plasticity of the nervous system at the systematic, cellular and molecular levels: a mechanism of chronic pain and hyperalgesia. Prog. Brain Res. 110:233-59